TORVANTA
Other · S&P 500 · data as of 2026-10-05

LGND stock analysis: LGND

LGND (LGND) is an S&P 500 company in Other. It grades strongest on growth and weakest on value.

The model's view of LGND · subscribers

Where LGND ranks among the 1,500 U.S. stocks the model scores each trading day, its expected return, the evidence for and against it, and whether the model portfolio holds it. The grades below describe the company's data; they are not the model's view.

See plans
What's happening with LGND · updated 2026-10-05 · from prices and SEC filings

LGND price performance

LGND against the S&P 500, one year
+0%+50%LGND +77%S&P 500 +18%2025-09-292026-10-05
Year to date+62.3%S&P 500 +14.5% · ahead by 47.7 pts
1 year+69.5%S&P 500 +17.0% · ahead by 52.5 pts
3 years+427.8%S&P 500 +89.3% · ahead by 338.6 pts
5 years+138.0%S&P 500 +91.3% · ahead by 46.7 pts

Total returns with dividends reinvested.

LGND factor grades

Each grade compares LGND with the rest of its sector (A+ best, F worst); the numbers behind it are shown with the typical figure for its peers.

DValueP/E 32.6x (industry 20.1x)FCF yield 2.1% (industry 6.0%)
A+GrowthRevenue growth +55% (industry +8%)
B+ProfitabilityOperating margin 32.6% (industry 9.6%)ROIC 7.2% (industry 10.1%)
B+Momentum12-month change +69%From 52-wk high -5%

LGND in plain numbers

LGND key statistics

SectorOther
Industryn/a
IndexS&P 500
Market value$6.1B
Revenue growth (y/y)+55%
Free-cash-flow yield2.1%
Dividend yieldn/a
Next earnings (expected)2026-11-05
Valuation measures
Market value$6.1B
Enterprise value$6.2B
P/E (trailing)32.6x
Forward P/E (Torvanta estimate)32.6x
Price / sales21.0x
Price / book6.3x
EV / revenue21.5x
EV / EBITDA48.8x
Financial highlights
Revenue, last 12 months$290.5M
Net income, last 12 months$197.2M
EPS, last 12 months (GAAP)$9.41
Operating margin32.6%
Net margin67.9%
Return on equity22.0%
Return on invested capital7.2%
Cash$1.0B
Total debt$1.1B
Debt / equity1.16x
Free cash flow, last 12 months$131.4M
Interest cover15.3x
Current ratio31.18x

Company figures from its latest SEC filings; market value and returns from end-of-day prices.

LGND earnings trends

Revenue vs earnings
-$42.5M-$2.5M$37.4M$77.3M$117.3MSep 2024 Revenue: $51.8MDec 2024 Revenue: $42.8MMar 2025 Revenue: $45.3MJun 2025 Revenue: $47.6MSep 2025 Revenue: $115.5MDec 2025 Revenue: $59.7MMar 2026 Revenue: $51.7MJun 2026 Revenue: $63.7MSep 2024 Net income: -$7.2MDec 2024 Net income: -$31.1MMar 2025 Net income: -$42.5MJun 2025 Net income: $4.8MSep 2025 Net income: $117.3MDec 2025 Net income: $44.8MMar 2026 Net income: -$13.3MJun 2026 Net income: $48.5MSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Net margin: -13.8%Net margin: -72.6%Net margin: -93.6%Net margin: 10.2%Net margin: 101.6%Net margin: 75.1%Net margin: -25.8%Net margin: 76.2%-94%4%102%■ Revenue ■ Net income ━ Net margin
Earnings per share$-2.2$-0.2$1.7$3.7$5.7Sep 2024 EPS (GAAP, diluted): $-0.4Dec 2024 EPS (GAAP, diluted): $-1.7Mar 2025 EPS (GAAP, diluted): $-2.2Jun 2025 EPS (GAAP, diluted): $0.2Sep 2025 EPS (GAAP, diluted): $5.7Dec 2025 EPS (GAAP, diluted): $2.2Mar 2026 EPS (GAAP, diluted): $-0.7Jun 2026 EPS (GAAP, diluted): $2.2Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026■ EPS (GAAP, diluted) Change from a year earlier: Jun 2026 +825%

From the company's 10-Q and 10-K filings with the SEC.

LGND financials (from SEC filings)

Fiscal yearFY2021FY2022FY2023FY2024FY2025
Revenue$261.1M$219.6M$131.3M$167.1M$268.1M
Net income$57.1M-$33.4M$52.2M-$4.0M$124.5M
EPS (GAAP)$3.31$-1.98$2.90$-0.20$5.89
Free cash flow$70.0M$119.9M$46.1M$95.2M$48.9M

LGND earnings history

ReportedEPS (GAAP)EPS y/yRevenue y/yStock vs S&P 500, 2 days
2026-08-06$2.22+825%+34%-3.6%
2026-05-07$-0.67n/a+14%-5.3%
2026-02-26$2.18n/a+39%+4.7%
2025-11-06$5.68n/a+123%+7.3%
2025-08-07$0.24n/a+15%+4.7%
2025-05-08$-2.21-147%+46%-1.7%

About LGND

HeadquartersSan Diego, CA
Industry (SEC code)Pharmaceutical Preparations
Fiscal year endsDecember 31
Incorporated inDE
Listed onNasdaq, OTC, OTC, OTC, OTC
FormerlyLIGAND PHARMACEUTICALS

From the company's SEC registration record.

Companies similar to LGND

CompanyMarket valueP/ERevenue growthOperating margin12-month change
LGND LGND$6.1B32.6x+55%32.6%+69%
ELF ELF$6.1B103.8x+31%7.2%-23%compare
INGR INGR$6.1B10.6x-1%11.9%-17%compare
FNB FNB$6.1B10.4xn/an/a+10%compare
CRUS CRUS$6.1B14.8x+6%23.0%-5%
GATX GATX$6.1B17.1x+23%n/a-1%
SFM SFM$6.1B12.4x+7%7.4%-39%

All Other stock ratings

Frequently asked questions

Is LGND stock a buy?

Torvanta does not tell individuals what to buy. Its grades for LGND are shown above. Subscribers see the model's rank, expected return and whether the model portfolio holds it. This is research, not a recommendation.

What is LGND's P/E ratio?

LGND trades at about 32.6 times its last 12 months of GAAP earnings reported to the SEC, and about 32.6 times Torvanta's own estimate of the next 12 months.

When does LGND report earnings next?

Based on its filing history, Torvanta expects LGND to report around 2026-11-05.

How has LGND performed against the S&P 500?

Over the past year LGND returned +69.5%, against +17.0% for the S&P 500, dividends reinvested.

See the model's view

Subscribers get the model's rank and expected return for every covered company, the reasoning behind each, and the Torvanta model portfolio's trades each trading day, sized and explained, at three risk levels.

See plans Or get the free weekly newsletter

Torvanta is research only - not investment advice and not a recommendation to buy or sell any security. Grades describe a company's reported data against its sector; they are not the model's view, change as data changes and can be wrong. Financial figures come from the company's SEC filings; returns include reinvested dividends. Past performance does not predict future results.

All stock ratings · Stock lists · AI stock research · Model portfolio · Research · Disclaimer